Evidence map›Paper›PMID 26330515›Full record

ArticlemBio2015

Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile.

Pierre Boudry, Ekaterina Semenova, Marc Monot, Kirill A Datsenko, Anna Lopatina, Ognjen Sekulovic, Maicol Ospina-Bedoya, Louis-Charles Fortier, Konstantin Severinov, Bruno Dupuy and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 72 citations in OpenAlex.

  1. Genomic and phenotypic insight intoEmerging microbes & infections · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Prophage Carriage and Genetic Diversity within Environmental Isolates ofInternational journal of molecular sciences · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Endogenous CRISPR/Cas systems for genome engineering in the acetogensFrontiers in bioengineering and biotechnology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Pierre BoudryLaboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Cellule Pasteur, Paris, France.
Ekaterina SemenovaWaksman Institute of Microbiology, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Marc MonotLaboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Paris, France.
Kirill A DatsenkoPurdue University, West Lafayette, Indiana, USA.
Anna LopatinaInstitutes of Molecular Genetics and Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Ognjen SekulovicDepartment of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Maicol Ospina-BedoyaDepartment of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Louis-Charles FortierDepartment of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Konstantin SeverinovWaksman Institute of Microbiology, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA Institutes of Molecular Genetics and Gene Biology, Russian Academy of Sciences, Moscow, Russia.
Bruno DupuyLaboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Paris, France.
Olga SoutourinaLaboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Cellule Pasteur, Paris, France olga.soutourina@pasteur.fr.
Université de Sherbrooke · CAInstitut Pasteur · FRSorbonne Paris Cité · FRInstitute of Gene Biology · RUPurdue University West Lafayette · USRussian Academy of Sciences · RURutgers, The State University of New Jersey · US

Funding

The Function of Small RNA-Based viral Defense System in E. coli - Renewal 1R01GM104071 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI SEMENOVA, EKATERINA · 2013 to 2024
$3.9M
NIGMS NIH HHS R01 GM10407NIGMS NIH HHS R01 GM104071
6 · The paper itself

Abstract

unlabelledClostridium difficile is the cause of most frequently occurring nosocomial diarrhea worldwide. As an enteropathogen, C. difficile must be exposed to multiple exogenous genetic elements in bacteriophage-rich gut communities. CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) systems allow bacteria to adapt to foreign genetic invaders. Our recent data revealed active expression and processing of CRISPR RNAs from multiple type I-B CRISPR arrays in C. difficile reference strain 630. Here, we demonstrate active expression of CRISPR arrays in strain R20291, an epidemic C. difficile strain. Through genome sequencing and host range analysis of several new C. difficile phages and plasmid conjugation experiments, we provide evidence of defensive function of the CRISPR-Cas system in both C. difficile strains. We further demonstrate that C. difficile Cas proteins are capable of interference in a heterologous host, Escherichia coli. These data set the stage for mechanistic and physiological analyses of CRISPR-Cas-mediated interactions of important global human pathogen with its genetic parasites. IMPORTANCE: Clostridium difficile is the major cause of nosocomial infections associated with antibiotic therapy worldwide. To survive in bacteriophage-rich gut communities, enteropathogens must develop efficient systems for defense against foreign DNA elements. CRISPR-Cas systems have recently taken center stage among various anti-invader bacterial defense systems. We provide experimental evidence for the function of the C. difficile CRISPR system against plasmid DNA and bacteriophages. These data demonstrate the original features of active C. difficile CRISPR system and bring important insights into the interactions of this major enteropathogen with foreign DNA invaders during its infection cycle.

Indexed as

CRISPR-Cas SystemsGene Expression ProfilingClostridioides difficileDNA, BacterialEscherichia coliMolecular Sequence DataRNA, ViralSequence Analysis, DNADNA, BacterialRNA, Viral

Identifiers

PMID26330515
PMCPMC4556805
OpenAlexW2109565914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.